Medical Complications after Lung Transplantation

ABSTRACT

Despite remarkable progress in short-term functional and survival outcomes following lung transplantation, long-term outcomes remain limited due to a multitude of medical complications caused predominantly by immunosuppressive protocols. Although chronic allograft rejection and infection account for the majority of deaths beyond the first year after lung transplantation, a large number of other medical problems contribute significantly to excess mortality and morbidity. This article reviews the most frequent and important medical complications of lung transplantation, other than rejection and infection, with an emphasis on complications that involve the respiratory tract.

Lung transplantation - complications - posttransplant malignancy - venous thromboembolism - immunosuppression

REFERENCES

• 1 Reitz B A, Wallwork J L, Hunt S A et al.. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.  N Engl J Med. 1982;  306 557-564
• 2 Trulock E P, Edwards L B, Taylor D O, Boucek M M, Keck B M, Hertz M I. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005.  J Heart Lung Transplant. 2005;  24 956-967
• 3 Arcasoy S M. Medical complications and management of lung transplant recipients.  Respir Care Clin N Am. 2004;  10 505-529
• 4 Konen E, Weisbrod G L, Pakhale S, Chung T, Paul N S, Hutcheon M A. Fibrosis of the upper lobes: a newly identified late-onset complication after lung transplantation?.  AJR Am J Roentgenol. 2003;  181 1539-1543
• 5 Pakhale S S, Hadjiliadis D, Howell D N et al.. Upper lobe fibrosis: a novel manifestation of chronic allograft dysfunction in lung transplantation.  J Heart Lung Transplant. 2005;  24 1260-1268
• 6 Collins J, Hartman M J, Warner T F et al.. Frequency and CT findings of recurrent disease after lung transplantation.  Radiology. 2001;  219 503-509
• 7 Kazerooni E A, Cascade P N. Recurrent miliary sarcoidosis after lung transplantation.  Radiology. 1995;  194 913
• 8 Kazerooni E A, Jackson C, Cascade P N. Sarcoidosis: recurrence of primary disease in transplanted lungs.  Radiology. 1994;  192 461-464
• 9 Yeatman M, McNeil K, Smith J A et al.. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital.  J Heart Lung Transplant. 1996;  15 144-149
• 10 Johnson B A, Duncan S R, Ohori N P et al.. Recurrence of sarcoidosis in pulmonary allograft recipients.  Am Rev Respir Dis. 1993;  148 1373-1377
• 11 Bjortuft O, Foerster A, Boe J, Geiran O. Single-lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient.  J Heart Lung Transplant. 1994;  13 24-29
• 12 Carre P, Rouquette I, Durand D et al.. Recurrence of sarcoidosis in a human lung allograft.  Transplant Proc. 1995;  27 1686
• 13 Martinez F J, Orens J B, Deeb M, Brunsting L A, Flint A, Lynch III J P. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation.  Chest. 1994;  106 1597-1599
• 14 Muller C, Briegel J, Haller M et al.. Sarcoidosis recurrence following lung transplantation.  Transplantation. 1996;  61 1117-1119
• 15 Etienne B, Bertocchi M, Gamondes J P et al.. Relapsing pulmonary Langerhans' cell histiocytosis after lung transplantation.  Am J Respir Crit Care Med. 1998;  157 288-291
• 16 Gabbay E, Dark J H, Ashcroft T et al.. Recurrence of Langerhans' cell granulomatosis following lung transplantation.  Thorax. 1998;  53 326-327
• 17 Habib S B, Congleton J, Carr D et al.. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation.  Thorax. 1998;  53 323-325
• 18 Dauriat G, Mal H, Thabut G et al.. Lung transplantation for pulmonary Langerhans' cell histiocytosis: a multicenter analysis.  Transplantation. 2006;  81 746-750
• 19 O'Brien J D, Lium J H, Parosa J F, Deyoung B R, Wick M R, Trulock E P. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation.  Am J Respir Crit Care Med. 1995;  151 2033-2036
• 20 Bittmann I, Dose T B, Muller C, Dienemann H, Vogelmeier C, Lohrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantation.  Hum Pathol. 1997;  28 1420-1423
• 21 Boehler A, Speich R, Russi E W, Weder W. Lung transplantation for lymphangioleiomyomatosis.  N Engl J Med. 1996;  335 1275-1280
• 22 Nine J S, Yousem S A, Paradis I L, Keenan R, Griffith B P. Lymphangioleiomyomatosis: recurrence after lung transplantation.  J Heart Lung Transplant. 1994;  13 714-719
• 23 Garver Jr R I, Zorn G L, Wu X, McGiffin D C, Young Jr K R, Pinkard N B. Recurrence of bronchioloalveolar carcinoma in transplanted lungs.  N Engl J Med. 1999;  340 1071-1074
• 24 de Perrot M, Chernenko S, Waddell T K et al.. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease.  J Clin Oncol. 2004;  22 4351-4356
• 25 Baz M A, Kussin P S, Van Trigt P, Davis R D, Roggli V L, Tapson V F. Recurrence of diffuse panbronchiolitis after lung transplantation.  Am J Respir Crit Care Med. 1995;  151 895-898
• 26 King M B, Jessurun J, Hertz M I. Recurrence of desquamative interstitial pneumonia after lung transplantation.  Am J Respir Crit Care Med. 1997;  156 2003-2005
• 27 Frost A E, Keller C A, Brown R W et al.. Giant cell interstitial pneumonitis: disease recurrence in the transplanted lung.  Am Rev Respir Dis. 1993;  148 1401-1404
• 28 Calabrese F, Giacometti C, Rea F et al.. Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation.  Transplantation. 2002;  74 1643-1645
• 29 Cook R C, Fradet G, English J C et al.. Recurrence of intravenous talc granulomatosis following single lung transplantation.  Can Respir J. 1998;  5 511-514
• 30 Parker L A, Novotny D B. Recurrent alveolar proteinosis following double lung transplantation.  Chest. 1997;  111 1457-1458
• 31 Stewart S, McNeil K, Nashef S A, Wells F C, Higenbottam T W, Wallwork J. Audit of referral and explant diagnoses in lung transplantation: a pathologic study of lungs removed for parenchymal disease.  J Heart Lung Transplant. 1995;  14 1173-1186
• 32 Mal H, Guignabert C, Thabut G et al.. Recurrence of pulmonary emphysema in an alpha-1 proteinase inhibitor-deficient lung transplant recipient.  Am J Respir Crit Care Med. 2004;  170 811-814
• 33 Buell J F, Gross T G, Woodle E S. Malignancy after transplantation.  Transplantation. 2005;  80 S254-S264
• 34 Maurer J M, Frost A E, Glanville A R, Estenne M, Higenbottam T. International Guidelines for the Selection of Lung Transplant Candidates.  Am J Respir Crit Care Med. 1998;  158 335-339
• 35 Levine S M. A survey of clinical practice of lung transplantation in North America.  Chest. 2004;  125 1224-1238
• 36 Cohen J I. Epstein-Barr virus infection.  N Engl J Med. 2000;  343 481-492
• 37 Bakker N A, van Imhoff G W, Verschuuren E A et al.. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.  Clin Transplant. 2005;  19 327-334
• 38 Ramalingam P, Rybicki L, Smith M D et al.. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.  Mod Pathol. 2002;  15 647-656
• 39 Reams B D, McAdams H P, Howell D N, Steele M P, Davis R D, Palmer S M. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.  Chest. 2003;  124 1242-1249
• 40 Gao S Z, Chaparro S V, Perlroth M et al.. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.  J Heart Lung Transplant. 2003;  22 505-514
• 41 Benden C, Aurora P, Burch M et al.. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.  J Heart Lung Transplant. 2005;  24 2103-2108
• 42 Leung E, Shenton B K, Green K et al.. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.  Transpl Infect Dis. 2004;  6 156-164
• 43 Marom E M, McAdams H P, Butnor K J, Coleman R E. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients.  J Thorac Imaging. 2004;  19 74-78
• 44 Wigle D A, Chaparro C, Humar A, Hutcheon M A, Chan C K, Keshavjee S. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation.  Transplantation. 2001;  72 1783-1786
• 45 Paranjothi S, Yusen R D, Kraus M D, Lynch J P, Patterson G A, Trulock E P. Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.  J Heart Lung Transplant. 2001;  20 1054-1063
• 46 Hachem R R, Chakinala M M, Yusen R D et al.. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.  Transplantation. 2004;  77 431-437
• 47 Tsai D E, Hardy C L, Tomaszewski J E et al.. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients.  Transplantation. 2001;  71 1076-1088
• 48 Malouf M A, Chhajed P N, Hopkins P, Plit M, Turner J, Glanville A R. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.  J Heart Lung Transplant. 2002;  21 547-554
• 49 Knoop C, Kentos A, Remmelink M et al.. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.  Clin Transplant. 2006;  20 179-187
• 50 Oertel S H, Verschuuren E, Reinke P et al.. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).  Am J Transplant. 2005;  5 2901-2906
• 51 Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. a population-based cohort study.  Am J Respir Crit Care Med. 2000;  161 5-8
• 52 Arcasoy S M, Hersh C, Christie J D et al.. Bronchogenic carcinoma complicating lung transplantation.  J Heart Lung Transplant. 2001;  20 1044-1053
• 53 Collins J, Kazerooni E A, Lacomis J et al.. Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings.  Radiology. 2002;  224 131-138
• 54 Abrahams N A, Meziane M, Ramalingam P, Mehta A, DeCamp M, Farver C F. Incidence of primary neoplasms in explanted lungs: long-term follow-up from 214 lung transplant patients.  Transplant Proc. 2004;  36 2808-2811
• 55 Lee P, Minai O A, Mehta A C, DeCamp M M, Murthy S. Pulmonary nodules in lung transplant recipients: etiology and outcome.  Chest. 2004;  125 165-172
• 56 Ferrer J, Roldan J, Roman A et al.. Acute and chronic pleural complications in lung transplantation.  J Heart Lung Transplant. 2003;  22 1217-1225
• 57 Herridge M S, de Hoyos A L, Chaparro C, Winton T L, Kesten S, Maurer J R. Pleural complications in lung transplant recipients.  J Thorac Cardiovasc Surg. 1995;  110 22-26
• 58 Judson M A, Handy J R, Sahn S A. Pleural effusions following lung transplantation: time course, characteristics, and clinical implications.  Chest. 1996;  109 1190-1194
• 59 Judson M A, Handy J R, Sahn S A. Pleural effusion from acute lung rejection.  Chest. 1997;  111 1128-1130
• 60 Kroshus T J, Kshettry V R, Hertz M I, Bolman III R M. Deep venous thrombosis and pulmonary embolism after lung transplantation.  J Thorac Cardiovasc Surg. 1995;  110 540-544
• 61 Nathan S D, Barnett S D, Urban B A, Nowalk C, Moran B R, Burton N. Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients.  Chest. 2003;  123 1758-1763
• 62 Jankowich M D. Idiopathic pulmonary fibrosis in transplantation.  Chest. 2003;  124 2404 , author reply 2404-2405
• 63 Burns K E, Iacono A T. Incidence of clinically unsuspected pulmonary embolism in mechanically ventilated lung transplant recipients.  Transplantation. 2003;  76 964-968
• 64 Burns K E, Iacono A T. Pulmonary embolism on postmortem examination: an under-recognized complication in lung-transplant recipients?.  Transplantation. 2004;  77 692-698
• 65 Yegen H A, Lederer D J, Wilt J S et al.. Risk factors for venous thromboembolism in lung transplant recipient [abstract].  Am J Respir Crit Care Med. 2006;  3 A536
• 66 Hammoud D, Chin B. False-positive ventilation-perfusion scan in a patient with a transplanted lung.  Clin Nucl Med. 2003;  28 472-475
• 67 King-Biggs M B, Dunitz J M, Park S J, Kay Savik S, Hertz M I. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation.  Transplantation. 2003;  75 1437-1443
• 68 Groetzner J, Kur F, Spelsberg F et al.. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression.  J Heart Lung Transplant. 2004;  23 632-638
• 69 Vlahakis N E, Rickman O B, Morgenthaler T. Sirolimus-associated diffuse alveolar hemorrhage.  Mayo Clin Proc. 2004;  79 541-545
• 70 Morelon E, Stern M, Israel-Biet D et al.. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients.  Transplantation. 2001;  72 787-790
• 71 Morelon E, Stern M, Kreis H. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients.  N Engl J Med. 2000;  343 225-226
• 72 McWilliams T J, Levvey B J, Russell P A, Milne D G, Snell G I. Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation.  J Heart Lung Transplant. 2003;  22 210-213
• 73 Champion L, Stern M, Israel-Biet D et al.. Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients.  Ann Intern Med. 2006;  144 505-509
• 74 Lindenfeld J A, Simon S F, Zamora M R et al.. BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus.  Am J Transplant. 2005;  5 1392-1396
• 75 Garrean S, Massad M G, Tshibaka M, Hanhan Z, Caines A E, Benedetti E. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.  Clin Transplant. 2005;  19 698-703
• 76 Manito N, Kaplinsky E J, Bernat R et al.. Fatal interstitial pneumonitis associated with sirolimus therapy in a heart transplant recipient.  J Heart Lung Transplant. 2004;  23 780-782
• 77 Mal H, Brugiere O, Sleiman C et al.. Morbidity and mortality related to the native lung in single lung transplantation for emphysema.  J Heart Lung Transplant. 2000;  19 220-223
• 78 McAdams H P, Erasmus J J, Palmer S M. Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: incidence, radiologic features, and clinical importance.  Radiology. 2001;  218 233-241
• 79 Speziali G, McDougall J C, Midthun D E et al.. Native lung complications after single lung transplantation for emphysema.  Transpl Int. 1997;  10 113-115
• 80 Venuta F, Boehler A, Rendina E A et al.. Complications in the native lung after single lung transplantation.  Eur J Cardiothorac Surg. 1999;  16 54-58
• 81 Frost A E, Keller C A, Noon G P, Short H D, Cagle P T. Outcome of the native lung after single lung transplant. Multiorgan Transplant Group.  Chest. 1995;  107 981-984
• 82 Yonan N A, el-Gamel A, Egan J, Kakadellis J, Rahman A, Deiraniya A K. Single lung transplantation for emphysema: predictors for native lung hyperinflation.  J Heart Lung Transplant. 1998;  17 192-201
• 83 Weill D, Torres F, Hodges T N, Olmos J J, Zamora M R. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema.  J Heart Lung Transplant. 1999;  18 1080-1087
• 84 Moy M L, Loring S H, Ingenito E P, Mentzer S J, Reilly Jr J J. Causes of allograft dysfunction after single lung transplantation for emphysema: extrinsic restriction versus intrinsic obstruction. Brigham and Women's Hospital Lung Transplantation Group.  J Heart Lung Transplant. 1999;  18 986-993
• 85 Anderson M B, Kriett J M, Kapelanski D P, Perricone A, Smith C M, Jamieson S W. Volume reduction surgery in the native lung after single lung transplantation for emphysema.  J Heart Lung Transplant. 1997;  16 752-757
• 86 Schulman L L, O'Hair D P, Cantu E, McGregor C, Ginsberg M E. Salvage by volume reduction of chronic allograft rejection in emphysema.  J Heart Lung Transplant. 1999;  18 107-112
• 87 Venuta F, De Giacomo T, Rendina E A et al.. Thoracoscopic volume reduction of the native lung after single lung transplantation for emphysema.  Am J Respir Crit Care Med. 1998;  157 292-293
• 88 Kotloff R M, Ahya V N. Medical complications of lung transplantation.  Eur Respir J. 2004;  23 334-342
• 89 Verleden G M, Besse T, Maes B. Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient.  Transplantation. 2002;  73 1974-1976
• 90 Weinkauf J G, Yiannopoulos A, Faul J L. Transcutaneous electrical nerve stimulation for severe gastroparesis after lung transplantation.  J Heart Lung Transplant. 2005;  24 1444.e1-1444.e3
• 91 Yiannopoulos A, Shafazand S, Ziedalski T et al.. Gastric pacing for severe gastroparesis in a heart-lung transplant recipient.  J Heart Lung Transplant. 2004;  23 371-374
• 92 Young L R, Hadjiliadis D, Davis R D, Palmer S M. Lung transplantation exacerbates gastroesophageal reflux disease.  Chest. 2003;  124 1689-1693
• 93 D'Ovidio F, Singer L G, Hadjiliadis D et al.. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant.  Ann Thorac Surg. 2005;  80 1254-1260
• 94 D'Ovidio F, Mura M, Tsang M et al.. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.  J Thorac Cardiovasc Surg. 2005;  129 1144-1152
• 95 Hadjiliadis D, Duane Davis R, Steele M P et al.. Gastroesophageal reflux disease in lung transplant recipients.  Clin Transplant. 2003;  17 363-368
• 96 Palmer S M, Miralles A P, Howell D N, Brazer S R, Tapson V F, Davis R D. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation.  Chest. 2000;  118 1214-1217
• 97 Davis Jr R D, Lau C L, Eubanks S et al.. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.  J Thorac Cardiovasc Surg. 2003;  125 533-542
• 98 Smith P C, Slaughter M S, Petty M G, Shumway S J, Kshettry V R, Bolman III R M. Abdominal complications after lung transplantation.  J Heart Lung Transplant. 1995;  14 44-51
• 99 Gilljam M, Chaparro C, Tullis E, Chan C, Keshavjee S, Hutcheon M. GI complications after lung transplantation in patients with cystic fibrosis.  Chest. 2003;  123 37-41
• 100 Hoekstra H J, Hawkins K, de Boer W J, Rottier K, van der Bij W. Gastrointestinal complications in lung transplant survivors that require surgical intervention.  Br J Surg. 2001;  88 433-438
• 101 Lubetkin E I, Lipson D A, Palevsky H I et al.. GI complications after orthotopic lung transplantation.  Am J Gastroenterol. 1996;  91 2382-2390
• 102 Dellon E S, Morgan D R, Mohanty S P, Davis K, Aris R M. High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation.  Transplantation. 2006;  81 1141-1146
• 103 Hachem R R, Chakinala M M, Yusen R D et al.. Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.  Transplantation. 2004;  77 431-437
• 104 Calvet A, Pujol M O, Bertocchi M, Bastien O, Boissonnat P, Mornex J F. Parvovirus B19 infection in thoracic organ transplant recipients.  J Clin Virol. 1999;  13 37-42
• 105 Kariyawasam H H, Gyi K M, Hodson M E, Cohen B J. Anaemia in lung transplant patient caused by parvovirus B19.  Thorax. 2000;  55 619-620
• 106 Salerno C T, Burdine J, Perry E H, Kshettry V R, Hertz M I, Bolman III R M. Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart-lung and lung transplantation.  Transplantation. 1998;  65 261-264
• 107 Taaning E, Morling N, Mortensen S A, Pettersson G, Simonsen A C. Severe hemolysis caused by graft-derived anti-B production after lung transplantation.  J Heart Lung Transplant. 1996;  15 850-851
• 108 Qu L, Kiss J E. Thrombotic microangiopathy in transplantation and malignancy.  Semin Thromb Hemost. 2005;  31 691-699
• 109 Hachem R R, Yusen R D, Chakinala M M, Aloush A A, Patterson G A, Trulock E P. Thrombotic microangiopathy after lung transplantation.  Transplantation. 2006;  81 57-63
• 110 Goldfarb N S, Avery R K, Goormastic M et al.. Hypogammaglobulinemia in lung transplant recipients.  Transplantation. 2001;  71 242-246
• 111 Kawut S M, Shah L, Wilt J S et al.. Risk factors and outcomes of hypogammaglobulinemia after lung transplantation.  Transplantation. 2005;  79 1723-1726
• 112 Yip N H, Lederer D J, Kawut S M et al.. Immunoglobulin G levels before and after lung transplantation.  Am J Respir Crit Care Med. 2006;  173 917-921
• 113 Rocha P N, Rocha A T, Palmer S M, Davis R D, Smith S R. Acute renal failure after lung transplantation: incidence, predictors and impact on perioperative morbidity and mortality.  Am J Transplant. 2005;  5 1469-1476
• 114 Ishani A, Erturk S, Hertz M I, Matas A J, Savik K, Rosenberg M E. Predictors of renal function following lung or heart-lung transplantation.  Kidney Int. 2002;  61 2228-2234
• 115 Venuta F, De Giacomo T, Rendina E A et al.. Recovery of chronic renal impairment with sirolimus after lung transplantation.  Ann Thorac Surg. 2004;  78 1940-1943
• 116 Shitrit D, Rahamimov R, Gidon S et al.. Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study.  Kidney Int. 2005;  67 1471-1475
• 117 Chobanian A V, Bakris G L, Black H R et al.. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 2003;  42 1206-1252
• 118 Fletcher B, Berra K, Ades P et al.. Managing abnormal blood lipids: a collaborative approach.  Circulation. 2005;  112 3184-3209
• 119 Johnson B A, Iacono A T, Zeevi A, McCurry K R, Duncan S R. Statin use is associated with improved function and survival of lung allografts.  Am J Respir Crit Care Med. 2003;  167 1271-1278